Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

How has the spine biologics market grown in recent years?

In recent times, the spine biologics market has shown considerable growth. Forecasting an increase from $2.36 billion in 2024 to $2.49 billion in 2025, it indicates a compound annual growth rate (CAGR) of 5.7%. The substantial expansion in the historic phase is a result of progress in biotechnology, an increase in the number of aged individuals, a high occurrence of spinal conditions, a rising inclination towards minimally invasive procedures, heightened understanding of spinal health, advancements in diagnostic methods, and improvements in healthcare infrastructure.

How is the spine biologics market size expected to evolve during the forecast period?

The spine biologics market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to technological innovations, increasing adoption of regenerative medicine, rising investment in R&D, growing prevalence of obesity and sedentary lifestyles, expanding healthcare access in emerging markets, favorable regulatory approvals, and increasing collaborations and partnerships within the industry. Major trends in the forecast period include emergence of novel regenerative therapies, integration of artificial intelligence in treatment planning, expansion of personalized medicine approaches, adoption of 3D printing for customized implants, and development of bioengineered scaffolds for enhanced tissue regeneration.

Get your spine biologics market report here!

https://www.thebusinessresearchcompany.com/report/spine-biologics-global-market-report

Which key drivers are propelling the spine biologics market’s growth?

The increasing incidence of road mishaps is predicted to bolster the rise of the spinal biologics market. A road mishap is an unprecedented and unanticipated occurrence involving one or more vehicles on a public roadway, frequently resulting in severe spinal trauma that necessitates sophisticated medical treatments for efficient treatment and recovery. Various factors, such as driver distraction, escalating traffic volume, subpar road conditions and infrastructure, and the misuse of alcohol and drugs, contribute to the global increase in road accidents. Spinal biologics are critical in enhancing patient results by promoting spinal fusion, accelerating healing, reducing surgical dangers, improving pain management, and minimizing the requirement for subsequent corrective surgeries. For example, the National Highway Traffic Safety Administration, a U.S. government agency, reported in May 2022 that an approximate 42,915 individuals perished in car accidents in the previous year, a 10.5% increase from 38,824 deaths in 2020 in the U.S. Therefore, the escalating frequency of road accidents is pushing the growth of the spinal biologics market.

What are the market segments in the spine biologics industry?

The spine biologics market covered in this report is segmented –

1) By Product: Bone Allografts, Bone Graft Substitute, Platelet Rich Plasma, Bone Marrow Aspirate Therapy

2) By Surgery Type: Anterior Cervical Discectomy And Fusion (ACDF), ??Posterior Lumbar Interbody Fusion (PLIF), Transforaminal Lumbar Interbody Fusion (TLIF), ??Anterior Lumbar Interbody Fusion (ALIF), ??Lateral Lumbar Interbody Fusion (LLIF), Other Surgery Types

3) By Application: Spinal Fusion, Spinal Non-Union And Fracture Repair, Degenerative Disc Disease Treatment, Other Applications

4) By End User: Hospitals, Spinal Surgery Centers, Orthopedic Clinics, Other End Users

Subsegments:

1) By Bone Allografts: Fresh Allografts, Freeze-Dried Allografts

2) By Bone Graft Substitute: Synthetic Bone Grafts, Demineralized Bone Matrix (DBM), Calcium Phosphate-Based Grafts, Platelet Rich Plasma (PRP)

3) By Bone Marrow Aspirate Therapy: Concentrated Bone Marrow Aspirate, Bone Marrow Concentrates

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15928&type=smp

Who are the key players steering the development of the spine biologics market?

Major companies operating in the spine biologics market are Johnson & Johnson Services Inc., Medtronic PLC, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Zimmer Biomet Holdings Inc., Arthrex Inc., Integra LifeSciences Corporation, Bone Biologics Corp., InVivo Therapeutics Corp., RTI Surgical Inc., Paragon 28 Inc., LifeNet Health Inc., Xtant Medical Holdings Inc., Kuros Biosciences A.G., CoreLink LLC, Spinal Elements Inc., Life Spine Inc., Innovasis Inc., Camber Spine Technologies LLC, SurGenTec LLC, ChoiceSpine LLC, Cerapedics Inc., Aziyo Biologics, Amedica Corporation

What are the key trends shaping the future of the spine biologics market?

The spinal biologics market is witnessing advancements in product development by leading companies, with a focus on artificial bioactive bone grafts. These grafts are designed with innovative spine biologic technology to bolster and expedite the process of bone growth and healing during spinal fusion surgeries. One such notable advancement is the introduction of Opus BA, a synthetic bioactive bone graft by a US-based firm, Orthofix Medical Inc., in February 2022. Opus BA is used in cervical and lumbar spine fusion surgeries and is available in putty and strip variants. It serves as a platform for bone growth, which gets absorbed and subsequently replaced by natural bone. It can be moisturized with autogenous bone marrow or autografted with saline. The product incorporates a matrix encouraging bone growth and dissolution, comprised of carbonate apatite bone mineral, bioactive glass, and Type 1 collagen.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15928

What regions are contributing significantly to the growth of the spine biologics market?

North America was the largest region in the spine biologics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the spine biologics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Spine Implants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/spine-implants-global-market-report

Wheel Spindle Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/wheel-spindle-global-market-report

Acute Spinal Cord Injury Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/acute-spinal-cord-injury-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: